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LEVEL OF EVIDENCE: III
Chlamydia trachomatis is the most com mon bacterial sexu ally transmitted disease in the United States. In 2002, 834,555 new Chlamydia infections were reported to the Centers for Disease Control and Prevention (C D C ). In women, the rate is now 455 cases per 100,000 popula tion. '9 These studies were performed using culture techniques. Because cell culture techniques are only 65-85°/o sensitive, questions arise as to whether the observed clearance was a spontaneous cure or failure o f die cell culture. One study using D N A amplification techniques confirmed that die clearance o f asymptomadc Chlamydia does occur (28%) in both men and nonpreg nant women. Resolution was associated with increasing age and time from diagnosis to follow-up studies, impli cating a host-immune response to chlamydial infection.10 This angle has not yet been evaluated in pregnant women widi asymptomadc chlamydial infection-spontaneous res olution rates may be lower based on die potential for an altered host-immune response in pregnancy. The objec tives o f diis analysis were to estimate die rate o f spontane ous resolution (clearance) o f asymptomadc C trachomatis in pregnancy and to evaluate die clinical factors associated widi die spontaneous resolution.
M ATERIALS AND METHODS
This study is a secondary analysis o f data obtained during a randomized, double-masked multicenter clini cal trial conducted by The National Institute o f Child Health and Human Development Maternal-Fetal M ed icine Units Network. In die randomized trial, 21,965 pregnant women were screened for bacterial vaginosis between 8 weeks, 0 days and 22 weeks, 6 days o f gestation. Screening, eligibility, and exclusion criteria for the cohort have been described previously.11 Briefly, women were ineligible for screening if they reported vaginal discharge with itching, burning, or odor; an allergy to metronidazole; ethanol abuse; antibiotic ther apy within die previous 14 days; plans to deliver at another institution; cervical cerclage; preterm labor be fore screening; fetal death or life-threatening anomaly; multifetal gestation; or medical illness requiring long term or intermittent drug dierapy. W om en who were found to have asymptomatic bacterial vaginosis were randomly assigned between 16 weeks, 0 days and 23 weeks, 6 days o f gestation to 1 o f 2 treatment groups: 2 g o f metronidazole or a lactose placebo. The dose was repeated at 48 hours and then again at a follow-up visit between 24 weeks, 0 days and 29 weeks, 6 days o f gestation. The primary aim o f the trial was to estimate whether the treatment o f asymptomatic bacterial vagino sis decreased the risk o f preterm delivery. The results o f this trial previously have been reported.11
During the study period, voided urine samples were collected before treatment at die randomization and at die follow-up visits. The urine specimens were frozen at -70°C and archived at 1 institution (University o f Alabama at Birmingham). Analysis was performed subsequent to com pletion o f die trial. A ligase chain reaction for genitourinary C trachomatis infection was performed in this central location. The ligase chain reaction is specific for C frachmm fis plasmid DNA. Ligase chain reaction has been shown to be a highly effective, sensitive, and specific assay for genitourinary C trachomatis}2" 15 Specifically, ligase chain reaction o f urine in pregnant women has been reported to be 84% sensitive and 99.5% specific,12 which is a marked improvement over standard culture techniques. The results o f die ligase chain reaction assays were not available to clinicians managing die women, and no one standardized Chlamydia screening program was mandated at die participating centers.
W om en who did not have a randomization and a follow-up urine ligase chain reaction were excluded from diis analysis, as were women widi symptomatic C tracho matis genital infections. Symptoms included vaginal dis charge and pruritus. Antibiotic use for any indication was recorded in the database. W om en receiving antibi otics between randomization and follow-up reported to be effective for Chlamydia, specifically amoxicillin, peni cillin derivatives, clindamycin, azithromycin, chloram phenicol, any fluoroquinolone, erythromycin, doxycycline, and rifampin, also were excluded. The study was approved by die institutional review boards o f the par ticipating centers. Informed consent was obtained from all women before randomization.
The data were analyzed using the Fisher exact, or Mantel-Haenszel tests where appropriate. Logistic re gression also was performed, and odds ratios (ORs) with 95°/o confidence intervals (CIs) were determined. Nomi nal P values were reported and adjustments were not made for multiple comparisons. A 2-sided P < .05 was considered significant. All analyses were performed us ing SAS 8 (SAS Institute, Cary, NC).
RESULTS
A total o f 1,953 women were randomly assigned into the bacterial vaginosis trial published previously (Fig. I) .11 O f these, 406 (21%) women did not have a randomiza tion and/or follow-up urine ligase chain reaction results for C, trachomatis. O f the remaining 1,547 women, 23 (1.5%) were excluded secondary to antibiotic use effec tive against C, trachomatis, and 3 were excluded secondary to symptomatic Chlamydia infection. The final population for this study included 1,521 pregnant women without symptoms o f genitourinary Chlamydia. Approximately 9%, or 140 women, were positive for C trachomatis at randomization and thus were diagnosed with asymp tomatic chlamydial infection. Sixty-one o f the women who initially tested positive (44%) were negative for C trachomatis on the follow-up urine ligase chain reaction, indicating spontaneous clearance o f their asymptomatic infection.
The C, trachomatis ligase chain reaction positive rate at randomization was not different between the metronida zole and placebo groups (9.3% and 9.1%, respectively, P = .08). Also, no significant difference was found be tween the 2 groups with regard to Chlamydia resolution rates (41% and 46%, respectively, P = .51). Therefore, the data in the 2 treatment arms were combined for the remaining analyses. Table 1 details the demographic data o f the ligase chain reaction-positive women who spontaneously cleared C, trachomatis compared with those with persistent infection. Although race, nulliparity, and insurance sta tus did not differ between the 2 groups, age was a significant factor. Increasing age was associated with a greater likelihood o f a negative follow-up C, trachomatis ligase chain reaction result (P = .01 for age as a contin uous variable).
Factors previously reported to be associated with spontaneous Chlamydia clearance in animals, men, and nonpregnant women are listed in Table 2 . A greater number o f lifetime sexual partners and a testing interval o f more than 5 weeks from randomization to follow-up ligase chain reaction testing were associated with spon taneous clearance o f C, trachomatis in the univariant model (P = .02 and 0.02, respectively). N o women in either group had a diagnosis o f human immunodeficiency vi rus (HTV). Alcohol and tobacco use also did not differ between the groups. The vaginal milieu, characterized by using Gram stain Nugent criteria scoring and vaginal pH at randomization and follow-up, had no effect on chlamydial clearance (Table 3) . Bacterial vaginosis is defined as a Gram stain ing score o f 7 or greater in conjunction with a vaginal pH o f more than 4.5. These parameters were used to assess whether changes in the vaginal milieu, consistent with bacterial vaginosis, would affect Chlamydia clearance.
Age, number o f lifetime sexual partners, and the inter val o f time between each ligase chain reaction test all were associated with spontaneous clearance o f C tracho matis. W hen all 3 variables were included in a logistic regression model, maternal age (OR = 0.6, 95°/o C l 0 .4 -0 .9 per 5 years; P = .02) and follow-up interval o f more than 5 weeks (OR = 0.4,95% C l 0.2-0.9; P = .03) remained significant. For every 5-year increase in mater nal age, the odds o f ligase chain reaction positivity at follow-up decreased by 40°/o. Data reported as n (°/o).
Spontaneous resolution o f C trachomatis using a sensitive D N A assay occurred in 44°/o o f pregnant women with asymptomatic C trachomatis. Maternal age was the stron gest predictor o f resolution-the older the woman, the more likely she was to have spontaneous resolution. Increasing time interval between testing and the greater number o f lifetime sexual partners also were associated with resolution. A number o f previous studies have described the occurrence o f spontaneous clearance o f C trachomatis in both animals16-1' and humans.3-9-10 The limitations o f these earlier studies was the sensitivity o f the tissue culture-based testing (reported to be 65-85°/o).13-18 The argument can be made that the chlamydial infection did not resolve but that the cell culture failed. The advent o f D N A amplification technology (polymerase chain reac tion and ligase chain reaction) has made available highly sensitive and specific assays for C trachomatis} 2'15 These tests using both cervical and urine specimens have been validated in pregnancy12 and have been proven to be more cost-effective than tissue culture techniques.19 T o address the validity o f the tissue culture-based studies. Parks et al10 described a cohort o f men and nonpregnant women with chlamydial infection using D N A amplifica tion techniques. In this study, 28°/o o f patients spontane ously resolved their infection, which is similar to the resolution rate described in our cohort o f pregnant women with asymptomatic disease. These 2 studies con firm that spontaneous resolution o f Chlamydia frequently does occur.
The activation o f a host immune response is the most likely etiology for the spontaneous resolution o f Chlamydia. Over the course o f time, untreated animals have been found to resolve chlamydial infection.16-1' In hu mans, increasing age and increasing time interval be tween testing have been associated with spontaneous resolution, indicating either prior chlamydial infection with the development o f memory T cells or time to mount an immune response.10 Pregnancy has long been assumed to be associated with suppression o f humoral and cellular immunity to allow tolerance o f the fetus. The possibility o f this altered immune function in preg nancy could have decreased the clearance rate. H ow ever, we also found maternal age and time interval to be associated with resolution, as was a greater number o f lifetime sexual partners (increasing the chance o f prior chlamydial infection). These associations are all consis tent with a host immune-response mechanism.
The role o f Chlamydia infection in pregnancy compli cations, such as preterm delivery and preterm rupture o f membranes, has been controversial. Reports have varied based on sample size, study population, and diagnostic techniques used. Spontaneous clearance o f chlamydial infections may also explain some o f the varied results and should be addressed in subsequent analyses. This was a secondary analysis o f a large randomized controlled trial and, as such, has limitations that must be addressed. The sensitivity and specificity o f the ligase chain reaction are not 100°/o (as widi any laboratory test), and therefore the possibility o f false-positive and falsenegative results remain. However, diis D N A test is markedly better than previous culture techniques, and D N A amplification technology has become die " gold standard." A second limitation is diat die power calcula tions were performed for die original study, not diis secondary analysis. However, die numbers reported in diis work are adequate to address die rate o f spontane ous clearance o f Chlamydia and to determine risk factors associated widi diis finding.
The public healdi impact o f Chlamydia infection in die United States is without question. The rate o f asymp tomatic chlamydial infection in diis cohort o f pregnant women o f 9°/o stresses the importance o f screening all women during the prenatal period. Screening and subse quent treatment will not only decrease the risk o f neona tal complications but also decrease die rate o f long-term sequelae. Defining the spontaneous clearance rate (44%) and factors associated with resolution are important to our understanding o f the pathophysiology o f chlamydial infection. It also has major public health implications. Although 44% o f infections resolved, most women with asymptomatic Chlamydia who were not treated had per sistent infection. The importance o f adequate treatment and follow-up remains a high priority for clinicians.
